Literature DB >> 1706750

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex.

A Vitiello1, D Marchesini, J Furze, L A Sherman, R W Chesnut.   

Abstract

Transgenic murine lines have been constructed that express a chimeric class I molecule composed of the alpha 1 and alpha 2 domains of HLA-A2.1 and the alpha 3, transmembrane, and cytoplasmic domains of H-2Kb. Upon immunization with influenza virus, transgenic mice developed a strong A2.1Kb-restricted cytotoxic T lymphocyte (CTL) response specific for the same matrix protein epitope that serves as the dominant A2.1-restricted determinant in the equivalent human response. Fine specificity analysis of CTL clones using truncated peptides revealed strong similarity between the response repertoire of transgenic mice and that previously reported using influenza-specific A2.1-restricted CTL clones from humans. This suggests that even when considering T cell responses by different species, the alpha 1 and alpha 2 domains of the restriction element play a dominant role in determining the CTL specific repertoire. Thus, substituting the alpha 3 domain of A2.1 with a murine counterpart has permitted development of a transgenic strain that should serve as an excellent model system in studies of HLA-restricted responses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1706750      PMCID: PMC2190816          DOI: 10.1084/jem.173.4.1007

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  Murine cells expressing an HLA molecule are specifically lysed by HLA-restricted antiviral human T cells.

Authors:  E Gomard; B Begue; S Sodoyer; J L Maryanski; B R Jordan; J P Levy
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

2.  The conformation of Ld induced by beta 2-microglobulin is fixed during de novo synthesis and irreversible by exchange or dissociation.

Authors:  N B Myers; W R Lie; M Nett; R J Rubocki; T H Hansen
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

Review 3.  T-cell recognition of lysozyme: the biochemical basis of presentation.

Authors:  P M Allen; B P Babbitt; E R Unanue
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

4.  Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells.

Authors:  H S Teh; P Kisielow; B Scott; H Kishi; Y Uematsu; H Blüthmann; H von Boehmer
Journal:  Nature       Date:  1988-09-15       Impact factor: 49.962

5.  Beta 2-microglobulin restriction of antigen presentation.

Authors:  B Pérarnau; C A Siegrist; A Gillet; C Vincent; S Kimura; F A Lemonnier
Journal:  Nature       Date:  1990-08-23       Impact factor: 49.962

6.  Abnormal anti-viral immune response in mice is corrected in HLA-B27.2-transgenic mice.

Authors:  F Kievits; W Lokhorst; P Ivanyi
Journal:  Eur J Immunol       Date:  1990-05       Impact factor: 5.532

7.  Human beta 2-microglobulin specifically enhances cell-surface expression of HLA class I molecules in transfected murine cells.

Authors:  B M Perarnau; A C Gillet; R Hakem; M Barad; F A Lemonnier
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

8.  Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response.

Authors:  M J Irwin; W R Heath; L A Sherman
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

9.  Direct evidence for binding of CD8 to HLA class I antigens.

Authors:  Y Rosenstein; S Ratnofsky; S J Burakoff; S H Herrmann
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  The Lyt-2 molecule recognizes residues in the class I alpha 3 domain in allogeneic cytotoxic T cell responses.

Authors:  J M Connolly; T A Potter; E M Wormstall; T H Hansen
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  90 in total

1.  Mining the melanosome for tumor vaccine targets: P.polypeptide is a novel tumor-associated antigen.

Authors:  C E Touloukian; W W Leitner; P F Robbins; S A Rosenberg; N P Restifo
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

2.  DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.

Authors:  L Planelles; M C Thomas; C Alonso; M C López
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Marked enhancement of the antigen-specific immune response by combining plasmid DNA-based immunization with a Schiff base-forming drug.

Authors:  Jehad Charo; Maria Sundbäck; Ken Wasserman; Anne-Marie T Ciupitu; Babak Mirzai; Ruurd van der Zee; Rolf Kiessling
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.

Authors:  Christoph Esslinger; Laurence Chapatte; Daniela Finke; Isabelle Miconnet; Philippe Guillaume; Frédéric Lévy; H Robson MacDonald
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

5.  Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response.

Authors:  Ghislaine Gallez-Hawkins; Maria C Villacres; Xiuli Li; Margaret C Sanborn; Norma A Lomeli; John A Zaia
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 6.  Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.

Authors:  Jason Botten; John Sidney; Bianca R Mothé; Bjoern Peters; Alessandro Sette; Maya F Kotturi
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

7.  Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein.

Authors:  A Bertoletti; F V Chisari; A Penna; S Guilhot; L Galati; G Missale; P Fowler; H J Schlicht; A Vitiello; R C Chesnut
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.

Authors:  B Wizel; M Palmieri; C Mendoza; B Arana; J Sidney; A Sette; R Tarleton
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus.

Authors:  Michael D Robek; Mayra L Garcia; Bryan S Boyd; Francis V Chisari
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses.

Authors:  Yeping Sun; Jun Liu; Meng Yang; Feng Gao; Jianfang Zhou; Yoshihiro Kitamura; Bin Gao; Po Tien; Yuelong Shu; Aikichi Iwamoto; Zhu Chen; George F Gao
Journal:  J Gen Virol       Date:  2009-12-02       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.